{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:05:22Z","timestamp":1777431922786,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,6,4]],"date-time":"2005-06-04T00:00:00Z","timestamp":1117843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Brain Res"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00221-005-2243-8","type":"journal-article","created":{"date-parts":[[2005,6,6]],"date-time":"2005-06-06T14:26:30Z","timestamp":1118067990000},"page":"205-214","source":"Crossref","is-referenced-by-count":23,"title":["Statin treatment and a disease-specific pattern of \u03b2-amyloid peptides in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"164","author":[{"given":"Kina","family":"H\u00f6glund","sequence":"first","affiliation":[]},{"given":"Steinar","family":"Syversen","sequence":"additional","affiliation":[]},{"given":"Piotr","family":"Lewczuk","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Wallin","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2005,6,4]]},"reference":[{"key":"2243_CR1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0196-9781(02)00056-6","volume":"23","author":"N Andreasen","year":"2002","unstructured":"Andreasen N, Blennow K (2002) Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer\u2019s disease. Peptides 23:1205\u20131214","journal-title":"Peptides"},{"key":"2243_CR2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K (1999) Cerebrospinal fluid beta-amyloid(1\u201342) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56:673\u2013680","journal-title":"Arch Neurol"},{"key":"2243_CR3","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","volume":"39","author":"I Bj\u00f6rkhem","year":"1998","unstructured":"Bj\u00f6rkhem I, L\u00fctjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J (1998) Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 39:1594\u20131600","journal-title":"J Lipid Res"},{"key":"2243_CR4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"RA Black","year":"1997","unstructured":"Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729\u2013733","journal-title":"Nature"},{"key":"2243_CR5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"K Blennow","year":"2003","unstructured":"Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer\u2019s disease. Lancet Neurol 2:605\u2013613","journal-title":"Lancet Neurol"},{"key":"2243_CR6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s007020070052","volume":"107","author":"K Blennow","year":"2000","unstructured":"Blennow K, Ricksten A, Prince JA, Brookes AJ, Emahazion T, Wasslavik C, Bogdanovic N, Andreasen N, Batsman S, Marcusson J, Nagga K, Wallin A, Regland B, Olofsson H, Hesse C, Davidsson P, Minthon L, Jansson A, Palmqvist L, Rymo L (2000) No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer\u2019s disease, and no change in A2M mRNA, protein, or protein expression. J Neural Transm 107:1065\u20131079","journal-title":"J Neural Transm"},{"key":"2243_CR7","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1074\/jbc.271.8.4436","volume":"271","author":"S Bodovitz","year":"1996","unstructured":"Bodovitz S, Klein WL (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 271:4436\u20134440","journal-title":"J Biol Chem"},{"key":"2243_CR8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1212\/01.WNL.0000137041.86153.42","volume":"63","author":"D Bunce","year":"2004","unstructured":"Bunce D, Fratiglioni L, Small BJ, Winblad B, Backman L (2004) APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology 63:816\u2013821","journal-title":"Neurology"},{"key":"2243_CR9","doi-asserted-by":"crossref","first-page":"27765","DOI":"10.1074\/jbc.273.43.27765","volume":"273","author":"JD Buxbaum","year":"1998","unstructured":"Buxbaum JD, Liu KN, Luo Y, Slack JL, Stocking KL, Peschon JJ, Johnson RS, Castner BJ, Cerretti DP, Black RA (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273:27765\u201327767","journal-title":"J Biol Chem"},{"key":"2243_CR10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1046\/j.1471-4159.1995.65041431.x","volume":"65","author":"F Checler","year":"1995","unstructured":"Checler F (1995) Processing of the beta-amyloid precursor protein and its regulation in Alzheimer\u2019s disease. J Neurochem 65:1431\u20131444","journal-title":"J Neurochem"},{"key":"2243_CR11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0022-2275(20)31580-7","volume":"42","author":"SV Chochina","year":"2001","unstructured":"Chochina SV, Avdulov NA, Igbavboa U, Cleary JP, O\u2019Hare EO, Wood WG (2001) Amyloid beta-peptide(1\u201340) increases neuronal membrane fluidity. Role of cholesterol and brain region. J Lipid Res 42:1292\u20131297","journal-title":"J Lipid Res"},{"key":"2243_CR12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B De Strooper","year":"1998","unstructured":"De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391:387\u2013390","journal-title":"Nature"},{"key":"2243_CR13","doi-asserted-by":"crossref","first-page":"9712","DOI":"10.1073\/pnas.160115697","volume":"97","author":"M Farzan","year":"2000","unstructured":"Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choe H (2000) BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci USA 97:9712\u20139717","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR14","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","volume":"98","author":"K Fassbender","year":"2001","unstructured":"Fassbender K, Simons M, Bergmann C, Stroick M, L\u00fctjohann D, Keller P, Runz H, K\u00fchl S, Bertsch T, von Bergmann K, Hennerici M, Beyreuther K, Hartmann T (2001) Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 98:5856\u20135861","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR15","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/WNL.59.8.1257","volume":"59","author":"K Fassbender","year":"2002","unstructured":"Fassbender K, Stroick M, Bertsch T, Ragoschke A, Kuehl S, Walter S, Walter J, Brechtel K, Muehlhauser F, Von Bergmann K, L\u00fctjohann D (2002) Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology 59:1257\u20131258","journal-title":"Neurology"},{"key":"2243_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"2243_CR17","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/00001756-199906030-00014","volume":"10","author":"ER Frears","year":"1999","unstructured":"Frears ER, Stephens DJ, Walters CE, Davies H, Austen BM (1999) The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport 10:1699\u20131705","journal-title":"Neuroreport"},{"key":"2243_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"2243_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/S1461145701002310","volume":"4","author":"LT Friedhoff","year":"2001","unstructured":"Friedhoff LT, Cullen EI, Geoghagen NS, Buxbaum JD (2001) Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide. Int J Neuropsychopharmacol 4:127\u2013130","journal-title":"Int J Neuropsychopharmacol"},{"key":"2243_CR20","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm0997-1016","volume":"3","author":"T Hartmann","year":"1997","unstructured":"Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Allsop D, Roberts GW, Masters CL, Dotti CG, Unsicker K, Beyreuther K (1997) Distinct sites of intracellular production for Alzheimer\u2019s disease A beta40\/42 amyloid peptides. Nat Med 3:1016\u20131020","journal-title":"Nat Med"},{"key":"2243_CR21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.61.3.333","volume":"61","author":"K H\u00f6glund","year":"2004","unstructured":"H\u00f6glund K, Wiklund O, Vanderstichele H, Eikenberg O, Vanmechelen E, Blennow K (2004) Plasma levels of beta-amyloid(1\u201340), beta-amyloid(1\u201342), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins. Arch Neurol 61:333\u2013337","journal-title":"Arch Neurol"},{"key":"2243_CR67","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000084550","volume":"19","author":"H","year":"2005","unstructured":"H\u00f6glund K, Thelen K, Syversen S et al (2005) The effect of simvastatin treatment on the amyloid precursor protein in patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 19:256\u2013265","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2243_CR22","doi-asserted-by":"crossref","first-page":"22908","DOI":"10.1074\/jbc.271.37.22908","volume":"271","author":"N Ida","year":"1996","unstructured":"Ida N, Hartmann T, Pantel J, Schroder J, Zerfass R, Forstl H, Sandbrink R, Masters CL, Beyreuther K (1996) Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay. J Biol Chem 271:22908\u201322914","journal-title":"J Biol Chem"},{"key":"2243_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(03)00895-4","volume":"350","author":"K Ishii","year":"2003","unstructured":"Ishii K, Tokuda T, Matsushima T, Miya F, Shoji S, Ikeda S, Tamaoka A (2003) Pravastatin at 10\u00a0mg\/day does not decrease plasma levels of either amyloid-beta (Abeta) 40 or Abeta 42 in humans. Neurosci Lett 350:161\u2013164","journal-title":"Neurosci Lett"},{"key":"2243_CR24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.410370305","volume":"37","author":"T Iwatsubo","year":"1995","unstructured":"Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y (1995) Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Ann Neurol 37:294\u2013299","journal-title":"Ann Neurol"},{"key":"2243_CR25","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","volume":"356","author":"H Jick","year":"2000","unstructured":"Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA (2000) Statins and the risk of dementia. Lancet 356:1627\u20131631","journal-title":"Lancet"},{"key":"2243_CR26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(02)01654-4","volume":"65","author":"C Kirsch","year":"2003","unstructured":"Kirsch C, Eckert GP, Mueller WE (2003) Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol 65:843\u2013856","journal-title":"Biochem Pharmacol"},{"issue":"Pt 2","key":"2243_CR27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/bj3430371","volume":"343","author":"H Koike","year":"1999","unstructured":"Koike H, Tomioka S, Sorimachi H, Saido TC, Maruyama K, Okuyama A, Fujisawa-Sehara A, Ohno S, Suzuki K, Ishiura S (1999) Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem J 343(Pt 2):371\u2013375","journal-title":"Biochem J"},{"key":"2243_CR28","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1073\/pnas.081612998","volume":"98","author":"E Kojro","year":"2001","unstructured":"Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci USA 98:5815\u20135820","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR29","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","volume":"96","author":"S Lammich","year":"1999","unstructured":"Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 96:3922\u20133927","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/rcm.1048","volume":"17","author":"Lewczuk","year":"2003","unstructured":"Lewczuk P, Esselmann H, Meyer M, Wollscheid V, Neumann M, Otto M, Maler JM, Ruther E, Kornhuber J, Wiltfang J (2003) The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer\u2019s disease: evidence of a novel carboxyterminally elongated Abeta peptide. Rapid Commun Mass Spectrom 17:1291\u20131296","journal-title":"Rapid Commun Mass Spectrom"},{"key":"2243_CR31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am J Pathol 155:853\u2013862","journal-title":"Am J Pathol"},{"key":"2243_CR32","doi-asserted-by":"crossref","first-page":"18801","DOI":"10.1074\/jbc.274.26.18801","volume":"274","author":"RP Mason","year":"1999","unstructured":"Mason RP, Jacob RF, Walter MF, Mason PE, Avdulov NA, Chochina SV, Igbavboa U, Wood WG (1999) Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes. J Biol Chem 274:18801\u201318807","journal-title":"J Biol Chem"},{"key":"2243_CR33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"key":"2243_CR34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann Neurol 46:860\u2013866","journal-title":"Ann Neurol"},{"key":"2243_CR35","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1523\/JNEUROSCI.21-18-07226.2001","volume":"21","author":"M Michikawa","year":"2001","unstructured":"Michikawa M, Gong JS, Fan QW, Sawamura N, Yanagisawa K (2001) A novel action of Alzheimer\u2019s amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release. J Neurosci 21:7226\u20137235","journal-title":"J Neurosci"},{"key":"2243_CR36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1999.0720443.x","volume":"72","author":"J Mills","year":"1999","unstructured":"Mills J, Reiner PB (1999) Regulation of amyloid precursor protein cleavage. J Neurochem 72:443\u2013460","journal-title":"J Neurochem"},{"key":"2243_CR37","first-page":"627","volume":"24","author":"RC Mohs","year":"1988","unstructured":"Mohs RC, Cohen L (1988) Alzheimer\u2019s Disease Assessment Scale (ADAS). Psychopharmacol Bull 24:627\u2013628","journal-title":"Psychopharmacol Bull"},{"key":"2243_CR38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/385733a0","volume":"385","author":"ML Moss","year":"1997","unstructured":"Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD et al (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733\u2013736","journal-title":"Nature"},{"issue":"2","key":"2243_CR39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Ohlsson","year":"2005","unstructured":"Ohlsson A, Vanderstichele H, Andreasen N, Demeyer G, Holmberg G, Rosengren L, Vanmechelen E, Blennow K (2005) Simultaneous measurement of beta-amyloid(1\u201342), total tau and phosphorylated tau (Thr181) in cerebrospinal fluid using the xMAP technology. Clin Chem 51(2):336\u2013345","journal-title":"Clin Chem"},{"key":"2243_CR40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0197-4580(02)00155-0","volume":"24","author":"IH Park","year":"2003","unstructured":"Park IH, Hwang EM, Hong HS, Boo JH, Oh SS, Lee J, Jung MW, Bang OY, Kim SU, Mook-Jung I (2003) Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol Aging 24:637\u2013643","journal-title":"Neurobiol Aging"},{"key":"2243_CR41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.59.2.223","volume":"59","author":"K Rockwood","year":"2002","unstructured":"Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, Wolfson C, McDowell I (2002) Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 59:223\u2013227","journal-title":"Arch Neurol"},{"key":"2243_CR42","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1523\/JNEUROSCI.22-05-01679.2002","volume":"22","author":"H Runz","year":"2002","unstructured":"Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, Pepperkok R, Hartmann T (2002) Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci 22:1679\u20131689","journal-title":"J Neurosci"},{"key":"2243_CR43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med 2:864\u2013870","journal-title":"Nat Med"},{"key":"2243_CR44","doi-asserted-by":"crossref","first-page":"21286","DOI":"10.1074\/jbc.M209859200","volume":"278","author":"XP Shi","year":"2003","unstructured":"Shi XP, Tugusheva K, Bruce JE, Lucka A, Wu GX, Chen-Dodson E, Price E, Li Y, Xu M, Huang Q, Sardana MK, Hazuda DJ (2003) Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity. J Biol Chem 278:21286\u201321294","journal-title":"J Biol Chem"},{"key":"2243_CR45","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","volume":"95","author":"M Simons","year":"1998","unstructured":"Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460\u20136464","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR46","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ana.10292","volume":"52","author":"M Simons","year":"2002","unstructured":"Simons M, Schwarzler F, L\u00fctjohann D, von Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T, Schulz JB (2002) Treatment with simvastatin in normocholesterolemic patients with Alzheimer\u2019s disease: a 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 52:346\u2013350","journal-title":"Ann Neurol"},{"key":"2243_CR47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/990114","volume":"402","author":"S Sinha","year":"1999","unstructured":"Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomensaari SM, Wang S, Walker D, John V et al (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402:537\u2013540","journal-title":"Nature"},{"key":"2243_CR48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000069989","volume":"16","author":"M Sj\u00f6gren","year":"2003","unstructured":"Sj\u00f6gren M, Gustafsson K, Syversen S, Olsson A, Edman A, Davidsson P, Wallin A, Blennow K (2003) Treatment with Simvastatin in patients with Alzheimer\u2019s disease lowers both alpha- and beta-cleaved amyloid precursor protein. Dement Geriatr Cogn Disord 16:25\u201330","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2243_CR49","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993a","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993a) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977\u20131981","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR50","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993b","unstructured":"Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993b) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098\u20138102","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR51","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.112","volume":"49","author":"T Tokuda","year":"2001","unstructured":"Tokuda T, Tamaoka A, Matsuno S, Sakurai S, Shimada H, Morita H, Ikeda S (2001) Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins. Ann Neurol 49:546\u2013547","journal-title":"Ann Neurol"},{"key":"2243_CR52","doi-asserted-by":"crossref","first-page":"19304","DOI":"10.1074\/jbc.273.30.19304","volume":"273","author":"S Tomita","year":"1998","unstructured":"Tomita S, Kirino Y, Suzuki T (1998) A basic amino acid in the cytoplasmic domain of Alzheimer\u2019s beta-amyloid precursor protein (APP) is essential for cleavage of APP at the alpha-site. J Biol Chem 273:19304\u201319310","journal-title":"J Biol Chem"},{"key":"2243_CR53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0090-6980(98)00032-X","volume":"55","author":"B Urmoneit","year":"1998","unstructured":"Urmoneit B, Turner J, Dyrks T (1998) Cationic lipids (lipofectamine) and disturbance of cellular cholesterol and sphingomyelin distribution modulates gamma-secretase activity within amyloid precursor protein in vitro. Prostaglandins Other Lipid Mediat 55:331\u2013343","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2243_CR54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735\u2013741","journal-title":"Science"},{"key":"2243_CR55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/nbdi.2001.0470","volume":"9","author":"S Wahrle","year":"2002","unstructured":"Wahrle S, Das P, Nyborg AC, McLendon C, Shoji M, Kawarabayashi T, Younkin LH, Younkin SG, Golde TE (2002) Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis 9:11\u201323","journal-title":"Neurobiol Dis"},{"key":"2243_CR56","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1021\/bi015794o","volume":"41","author":"A Weidemann","year":"2002","unstructured":"Weidemann A, Eggert S, Reinhard FB, Vogel M, Paliga K, Baier G, Masters CL, Beyreuther K, Evin G (2002) A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41:2825\u20132835","journal-title":"Biochemistry"},{"key":"2243_CR57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/elps.1150120507","volume":"12","author":"J Wiltfang","year":"1991","unstructured":"Wiltfang J, Arold N, Neuhoff V (1991) A new multiphasic buffer system for sodium dodecyl sulfate-polyacrylamide gel electrophoresis of proteins and peptides with molecular masses 100,000\u20131,000, and their detection with picomolar sensitivity. Electrophoresis 12:352\u2013366","journal-title":"Electrophoresis"},{"key":"2243_CR58","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/elps.1150180332","volume":"18","author":"J Wiltfang","year":"1997","unstructured":"Wiltfang J, Smirnov A, Schnierstein B, Kelemen G, Matthies U, Klafki HW, Staufenbiel M, Huther G, Ruther E, Kornhuber J (1997) Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1\u201340, 1\u201342, and 1\u201343. Electrophoresis 18:527\u2013532","journal-title":"Electrophoresis"},{"key":"2243_CR59","doi-asserted-by":"crossref","first-page":"42645","DOI":"10.1074\/jbc.M102790200","volume":"276","author":"J Wiltfang","year":"2001","unstructured":"Wiltfang J, Esselmann H, Cupers P, Neumann M, Kretzschmar H, Beyermann M, Schleuder D, Jahn H, Ruther E, Kornhuber J, Annaert W, De Strooper B, Saftig P (2001) Elevation of beta-amyloid peptide 2\u201342 in sporadic and familial Alzheimer\u2019s disease and its generation in PS1 knockout cells. J Biol Chem 276:42645\u201342657","journal-title":"J Biol Chem"},{"key":"2243_CR60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"J Wiltfang","year":"2002","unstructured":"Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki HW, Maler M, Dyrks T, Bienert M, Beyermann M, Ruther E, Kornhuber J (2002) Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1\u201337\/38\/39 in addition to 1\u201340\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation. J Neurochem 81:481\u2013496","journal-title":"J Neurochem"},{"key":"2243_CR61","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.35.7.957","volume":"35","author":"KE Wisniewski","year":"1985","unstructured":"Wisniewski KE, Dalton AJ, McLachlan C, Wen GY, Wisniewski HM (1985) Alzheimer\u2019s disease in Down\u2019s syndrome: clinicopathologic studies. Neurology 35:957\u2013961","journal-title":"Neurology"},{"key":"2243_CR62","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","volume":"57","author":"B Wolozin","year":"2000","unstructured":"Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57:1439\u20131443","journal-title":"Arch Neurol"},{"key":"2243_CR63","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.59.3.378","volume":"59","author":"K Yaffe","year":"2002","unstructured":"Yaffe K, Barrett-Connor E, Lin F, Grady D (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 59:378\u2013384","journal-title":"Arch Neurol"},{"key":"2243_CR64","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnen\/59.8.723","volume":"59","author":"H Yamaguchi","year":"2000","unstructured":"Yamaguchi H, Maat-Schieman ML, van Duinen SG, Prins FA, Neeskens P, Natte R, Roos RA (2000) Amyloid beta protein (Abeta) starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects. J Neuropathol Exp Neurol 59:723\u2013732","journal-title":"J Neuropathol Exp Neurol"},{"key":"2243_CR65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/990107","volume":"402","author":"R Yan","year":"1999","unstructured":"Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME (1999) Membrane-anchored aspartyl protease with Alzheimer\u2019s disease beta-secretase activity. Nature 402:533\u2013537","journal-title":"Nature"},{"key":"2243_CR66","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/35024009","volume":"407","author":"G Yu","year":"2000","unstructured":"Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song YQ, Rogaeva E, Chen F, Kawarai T, Supala A, Levesque L, Yu H, Yang DS, Holmes E, Milman P, Liang Y, Zhang DM, Xu DH, Sato C, Rogaev E, Smith M, Janus C, Zhang Y, Aebersold R, Farrer LS, Sorbi S, Bruni A, Fraser P, St George-Hyslop P (2000) Nicastrin modulates presenilin-mediated notch\/glp-1 signal transduction and betaAPP processing. Nature 407:48\u201354","journal-title":"Nature"}],"container-title":["Experimental Brain Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-005-2243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00221-005-2243-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-005-2243-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T13:06:59Z","timestamp":1626008819000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00221-005-2243-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,4]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1007\/s00221-005-2243-8","relation":{},"ISSN":["0014-4819","1432-1106"],"issn-type":[{"value":"0014-4819","type":"print"},{"value":"1432-1106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,4]]}}}